Search Results 61-70 of 5014 for 搜索引擎营销咨询邮箱:lgooxc@hotmail.com
Mayo Clinic researcher Rachel A. Lindor, M.D., J.D., is an emergency physician researching the intersection of medicine, policy and law.
Joseph Maleszewski, M.D.. Associate Program Director Email: maleszewski.joseph@mayo.edu. Ann Mairose Education Program Coordinator Phone: 507-293-2866
FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma ( ...
About this study. The purpose of this study is to describe the proteome of mucus in patients without chronic rhinosinusitis (nCRS) with an emphasis on ...
About this study. This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a ...
About this study. This study is intended to understand the experiences and barriers to cancer care for individuals diagnosed with liver or any other type of ...
About this study. The purpose of this study is to assess whether our not the percentage of pulmonary related vascular structures (PRVS) determined by the ...
About this study. This is a phase 3, randomized, 2-arm, open-label, international trial evaluating alisertib compared with single-agent treatment, ...
Tumor Development, Immunology & Progression Lab of Peter Storz, Ph.D., at Mayo Clinic: Contact Dr. Storz about cancer research, cell signaling & pathways.
Dr. Nilüfer Ertekin-Taner discusses characteristics of neurodegenerative diseases and her research into the complex genetics of Alzheimer's at Mayo Clinic.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.